Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Antoniucci DM et al. – Study concludes that physicians should continue to prescribe adequate supplies of vitamin D within the target of therapy; for example, above 50 nmol/l during therapy with bisphosphonates, since adequate vitamin D levels counteract elevated parathyroid hormone levels, reduce bone resorption and have a positive effect on neuromuscular performance and on the risk of falling and bone strength.

Methods

Results


Exclusive Author Commentary
lems, 06/03/09

I am happy with the paper, since it is dealing with a clinically relevant question: are the widely prescribed bisphosphonates effective and safe in patients with low serum vitamin D levels. I suppose it is attractive for clinicians to read about the consequences of prescribing a bisphosphonate in patients with a low vitamin D level.

Today in Bone Metabolism...keeping you current

Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09

Cardiovascular diseases and risk of hip fracture
JAMA, 10/23/09

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial
Osteoporosis International, 10/06/09

Today in Clinical Pharmacology...keeping you current

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address